Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally

(Bloomberg) -- Gilead Sciences Inc. is considering acquiring a stake in Arcus Biosciences Inc., a cancer therapeutics company backed by Alphabet Inc., people familiar with the matter said.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.